Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
about
Epidemiology and socioeconomic impact of skin disease in lupus erythematosusPathogenesis of systemic lupus erythematosusThe influence of endogenous and exogenous sex hormones on systemic lupus erythematosus in pre- and postmenopausal womenHormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus?Epidemiologic studies of environmental agents and systemic autoimmune diseasesSafety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy.Menopause and the skin.Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.The neuropathology and pathogenesis of systemic lupus erythematosus.Estrogens and the vascular endothelium.MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases.Risks and benefits of hormone replacement therapy: the evidence speaks.Estrogen augments shear stress-induced signaling and gene expression in osteoblast-like cells via estrogen receptor-mediated expression of beta1-integrin.Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus.Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis.Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual.Estrogens, autoimmunity and the heart.Cigarette smoking and systemic lupus erythematosus: a smoking gun?Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus.Efficacy of proline in the treatment of menopause.Hormonal regulation of B-cell function and systemic lupus erythematosus.Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy.Estrogen and autoimmune disease.Menopause and Rheumatic Disease.Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil).Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy.Oral contraceptives and systemic lupus erythematosus.Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.Disassociation of sex hormone levels and cytokine production in SLE patients.Late onset lupus nephritis in Chinese patients: classified by the 2003 International Society of Nephrology and Renal Pathology Society system.Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity.Systemic lupus erythematosus in a multiethnic cohort (LUMINAXXXIX): relationship between hormone replacement therapy and disease activity over time.Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.Castration of male C57L/J mice increases susceptibility and estrogen treatment restores resistance to Theiler's virus-induced demyelinating disease.Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited.Identification of candidate genes that influence sex hormone-dependent disease phenotypes in mouse lupus.Why women?Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients.
P2860
Q22299248-E8510B40-38CB-46CA-8B44-5F21A42E6783Q24672873-2B587799-0476-4134-8CDC-FDF66494F8EEQ26795584-B2C5F393-8177-459C-AF98-7ADE57423CAEQ33692615-8D050B26-D83D-4BB4-B2FF-9778CFDA45AAQ33741193-0715B467-A764-4421-AF67-93CA5BECD39BQ34066226-3CAB5C01-9A35-4F79-A98B-44661BE3286DQ34227082-150FACDB-1084-4ADF-8C5E-FCFAF9745DEBQ34328005-3525BB97-A295-4D8C-A5BE-E6410DCAD8E9Q34333361-C631D2E5-8F31-489C-B254-D867D2862DE6Q34680879-D4BACF6A-E2B3-424F-9974-9A3AFDC4D3D0Q34735576-0E4E52A2-0E49-4D43-A360-5872F0CD39F9Q34772318-984569B4-B0C7-4E1E-9251-90AE44A3A620Q34899934-58E577CD-F74B-490F-A159-382540C0450EQ35156298-C0926EF6-CC9F-46C2-A59E-CA955D654571Q35553302-7472470F-36ED-4231-AB0A-1756B0EB094EQ35691674-019705D8-9F23-44F2-A924-AFDD9DB2A99FQ35763829-1DBCBC1C-1D10-4D7B-8B50-B1DB14C89EF5Q36283429-17833DAB-94F5-4EE2-8FF3-E5469298799BQ36350811-71C7EE2E-4B3B-41E5-814F-66342B7760E9Q36773713-EE12CC1E-28D4-43AA-98D2-CB6D15485103Q36843064-5037E668-3380-4571-8D12-FBB7DA8EDB1EQ37107101-122A505D-548B-4A20-A5AF-A4FC22744062Q37186307-06ADB755-1CDA-40F7-87C0-D08A82679B4DQ37260155-C039B8C9-B7DE-4B1D-989E-F1110E749CEEQ37698320-C6591CAB-F442-49A4-A3BA-CD59E3B07028Q38846584-46DDD204-B8E2-45D7-B3EE-7E9F2C0A9DF6Q39560849-9DFC8833-0F02-4DD7-BC82-D99DE146E8ACQ40748681-0DC822C8-AC5E-4C81-938B-CE9C332BA1ABQ41472074-A16766DB-6511-43DC-AE79-8B131D7BF12DQ43505242-91C6032E-70AB-4FCC-912B-821A205DF623Q43637708-60BD9CF1-14B5-4125-99C2-5BD87A229882Q43700012-56491262-0763-478B-8E51-321A066C98A7Q43853390-3B115479-EEE4-419B-A01B-4306B49836D7Q44042106-2BE083BB-BFC8-446D-BC45-66A31ECF6495Q44612340-60A71328-16E2-4673-8631-DE627EFF7D0AQ45407890-40634841-7591-441D-A990-883D26D84F4AQ45721965-745DCA2A-7C9C-4192-A5CC-05C6DC18B2DDQ46876197-149FDCA9-58B7-4FC0-8946-5D20AE580704Q50925267-99F4669E-A5E4-421A-94FA-D771675622F3Q51560916-95BA6ACB-7042-47BD-946A-7252DBCE54EE
P2860
Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
@en
type
label
Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
@en
prefLabel
Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
@en
P2093
P1476
Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
@en
P2093
Colditz GA
Karlson EW
Sánchez-Guerrero J
P304
P356
10.7326/0003-4819-122-6-199503150-00005
P407
P577
1995-03-01T00:00:00Z